Results

Total Results: 9,263 records

Showing results for "grade".
Users also searched for: grade

  1. pbrn.ahrq.gov/sites/default/files/wysiwyg/evidencenow/building-capacity/en-bsc-interim-report-2.pdf
    January 31, 2024 - best practices and that included simple messages, at accessible reading levels (no higher than 6th grade
  2. pcmh.ahrq.gov/sites/default/files/wysiwyg/evidencenow/building-capacity/en-bsc-interim-report-2.pdf
    January 31, 2024 - best practices and that included simple messages, at accessible reading levels (no higher than 6th grade
  3. ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/evidencenow/building-capacity/en-bsc-interim-report-2.pdf
    January 31, 2024 - best practices and that included simple messages, at accessible reading levels (no higher than 6th grade
  4. www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/building-capacity/en-bsc-interim-report-2.pdf
    July 01, 2024 - best practices and that included simple messages, at accessible reading levels (no higher than 6th grade
  5. www.cpsi.ahrq.gov/research/findings/nhqrdr/chartbooks/blackhealth/qdr-blackhealth-slides.html
    November 01, 2020 - Importance: Screening with Pap smears can detect high-grade precancerous cervical lesions that can be
  6. ce.effectivehealthcare.ahrq.gov/research/findings/nhqrdr/chartbooks/blackhealth/qdr-blackhealth-slides.html
    November 01, 2020 - Importance: Screening with Pap smears can detect high-grade precancerous cervical lesions that can be
  7. www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/chartbooks/2015qdr-chartbookblacks.pptx
    February 09, 2016 - Importance: Screening with Pap smears can detect high-grade precancerous cervical lesions that can be
  8. www.ahrq.gov/research/findings/nhqrdr/chartbooks/blackhealth/qdr-blackhealth-slides.html
    November 01, 2020 - Importance: Screening with Pap smears can detect high-grade precancerous cervical lesions that can be
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments-rapid-review.pdf
    March 01, 2024 - 70.95 Multi organ failure: 2/495, 0/479 RR = 4.83; CI: 0.23 to 100.13 Guillain-Barre Syndrome Grade
  10. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments-rapid-review.pdf
    March 01, 2024 - 70.95 Multi organ failure: 2/495, 0/479 RR = 4.83; CI: 0.23 to 100.13 Guillain-Barre Syndrome Grade
  11. ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/innovations/CommunityHubManual.pdf
    January 01, 2016 - Pathways Community HUB Manual A Pathways Community HUB Manual A Guide to Identify and Address Risk Factors, Reduce Costs, and Improve Outcomes Pathways Community HUB Manual A Guide to Identify and Address Risk Factors, Reduce Costs, and Improve Outcomes Prepared for: Agency for Healthcare Research and Qua…
  12. www.ahrq.gov/sites/default/files/wysiwyg/innovations/CommunityHubManual.pdf
    January 01, 2016 - Pathways Community HUB Manual A Pathways Community HUB Manual A Guide to Identify and Address Risk Factors, Reduce Costs, and Improve Outcomes Pathways Community HUB Manual A Guide to Identify and Address Risk Factors, Reduce Costs, and Improve Outcomes Prepared for: Agency for Healthcare Research and Qua…
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/decision-models-guidance_methods.pdf
    October 01, 2016 - Guidance for the Conduct and Reporting of Modeling and Simulation Studies in the Context of Health Technology Assessment Methods Guide for Comparative Effectiveness Reviews Guidance for the Conduct and Reporting of Modeling and Simulation Studies in the Context of Health Technology Assessment Th…
  14. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/decision-models-guidance_methods.pdf
    October 01, 2016 - Guidance for the Conduct and Reporting of Modeling and Simulation Studies in the Context of Health Technology Assessment Methods Guide for Comparative Effectiveness Reviews Guidance for the Conduct and Reporting of Modeling and Simulation Studies in the Context of Health Technology Assessment Th…
  15. www.uspreventiveservicestaskforce.org/home/getfilebytoken/DYFdTVu-UY3h7CWGdA7Zkh
    July 20, 2021 - Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force Screening for Colorectal Cancer Updated Evidence Report and Systematic Review for the US Preventive Services Task Force Jennifer S. Lin, MD; Leslie A. Perdue, MPH; Nora B. Henrikson, PhD; Sarah I. …
  16. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/surveillance-report-3-noninvasive-nonpharma.pdf
    August 01, 2022 - Acute Treatments for Episodic Migraine: Surveillance Report 3 1 Acute Treatments for Episodic Migraine: Surveillance Report 3 Literature Update Period: December 31, 2021, through March 21, 2022 Background and Purpose This report is the third surveillance report for the Agency for Healthcare Research and Qual…
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-3-noninvasive-nonpharma.pdf
    August 01, 2022 - Acute Treatments for Episodic Migraine: Surveillance Report 3 1 Acute Treatments for Episodic Migraine: Surveillance Report 3 Literature Update Period: December 31, 2021, through March 21, 2022 Background and Purpose This report is the third surveillance report for the Agency for Healthcare Research and Qual…
  18. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/episodic-migraine-surveillance-report-3.pdf
    August 01, 2022 - Acute Treatments for Episodic Migraine: Surveillance Report 3 1 Acute Treatments for Episodic Migraine: Surveillance Report 3 Literature Update Period: December 31, 2021, through March 21, 2022 Background and Purpose This report is the third surveillance report for the Agency for Healthcare Research and …
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-3.pdf
    August 01, 2022 - Acute Treatments for Episodic Migraine: Surveillance Report 3 Acute Treatments for Episodic Migraine: Surveillance Report 3 Literature Update Period: December 31, 2021, through March 21, 2022 Background and Purpose This report is the third and final surveillance report for the Agency for Healthcare Research an…
  20. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-3.pdf
    August 01, 2022 - Acute Treatments for Episodic Migraine: Surveillance Report 3 Acute Treatments for Episodic Migraine: Surveillance Report 3 Literature Update Period: December 31, 2021, through March 21, 2022 Background and Purpose This report is the third and final surveillance report for the Agency for Healthcare Research an…